Ignite Creation Date:
2024-05-05 @ 7:02 PM
Last Modification Date:
2024-10-26 @ 9:40 AM
Study NCT ID:
NCT00590109
Status:
COMPLETED
Last Update Posted:
2021-12-28
First Post:
2007-12-26
Brief Title:
Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by Breast Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Study Overview
Official Title:
Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by Breast Cancer
Status:
COMPLETED
Status Verified Date:
2021-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this project is to further characterize inherited predisposition to breast cancer mediated by specific BRCA alleles BRACA1 185delAG and 5382insC BRCA2 6174delT among Jewish women
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| CA08748 | None | None | None |